NASDAQ:BNR 延时15分钟

成交量

Yu Sheng Han: Yu Sheng Han is the founder of Guangzhou Burning Rock Medical Examination Institute Co., Ltd. since 2014, holding the title of Chief Executive Officer & Executive Director. Mr. Han is the founder of Burning Rock Biotech Ltd. since 2014, holding the title of Chairman & Chief Executive Officer. Former job at BioTek Instruments LLC as General Manager-China Region from 2005 to 2009. Former job at Northern Light Venture Capital Investment Consulting Beijing as Associate from 2011 to 2013. Education includes an undergraduate degree from Jilin University conferred in 2000, a graduate degree from Peking Union Medical College conferred in 2003, and an MBA from Columbia Business School conferred in 2011.

Yu Sheng Han: Yu Sheng Han is the founder of Guangzhou Burning Rock Medical Examination Institute Co., Ltd. since 2014, holding the title of Chief Executive Officer & Executive Director. Mr. Han is the founder of Burning Rock Biotech Ltd. since 2014, holding the title of Chairman & Chief Executive Officer. Former job at BioTek Instruments LLC as General Manager-China Region from 2005 to 2009. Former job at Northern Light Venture Capital Investment Consulting Beijing as Associate from 2011 to 2013. Education includes an undergraduate degree from Jilin University conferred in 2000, a graduate degree from Peking Union Medical College conferred in 2003, and an MBA from Columbia Business School conferred in 2011.

Gang Lu: Gang Lu is currently a Director at Suzhou Kintor Pharmaceuticals, Inc., Jiangsu Yitong Biotechnology Co., Ltd., and Hunan Yihong Health Technology Co., Ltd. He is also a Director at Burning Rock Biotech Ltd. since 2014 and a Partner at Legend Star since 2009. Previously, he worked as a Non-Executive Director at Kintor Pharmaceutical Ltd. from 2019 to 2022. Mr. Lu holds a Master's in Business Administration from Tsinghua University and an undergraduate degree from Xidian University.

Feng Deng: Feng Deng founded Hillstone Networks (Beijing) Co., Ltd. in 2006, where he is working as Director from 2006, NetScreen Technologies, Inc. in 1997, where he worked as Director, Chief Strategy Officer & VP-Engineering from 1997 to 2004, Northern Light Venture Capital Development Ltd. in 2005, where he is working as Founding Managing Director from 2005, and various other companies. Mr. Deng also currently works at Sentons, Inc., as Director, City Media Co., Ltd., as Director, Tidal Systems, Inc., as Director, and various other companies. Mr. Deng also formerly worked at Tsinghua Entrepreneur & Executive Club, as Chairman, Telegent Systems, Inc., as Director from 2007 to 2013, Aerohive Networks, Inc., as Independent Director from 2006 to 2015, and various other companies. Mr. Deng received his graduate degree in 1993 from the University of Southern California, graduate degree in 1991 from Rutgers State University of New Jersey, undergraduate degree in 1986 from Tsinghua University, graduate degree in 1988 from Tsinghua University, and Masters Business Admin degree in 2005 from The Wharton School of the University of Pennsylvania.

Zhi Hong Zhang: Zhi Hong Zhang currently works at Burning Rock Biotech Ltd., as Chief Technology Officer & Director from 2023. Dr. Zhang received his doctorate degree in 2005 from Duke University, graduate degree in 2000 from Fudan University, and graduate degree in 1997 from Fudan University.

Wendy Hayes: Ms. Wendy Hayes is an Independent Director at Apollomics, Inc. (United States), an Independent Non-Executive Director at SciClone Pharmaceuticals (Holdings) Ltd., an Independent Director at iHuman, Inc., a Venture Partner at FoundersX LLC, an Independent Director at Burning Rock Biotech Ltd. and a Member at The American Institute of Certified Public Accountants. She is on the Board of Directors at Apollomics, Inc. (United States), SciClone Pharmaceuticals (Holdings) Ltd., iHuman, Inc. and Burning Rock Biotech Ltd. Ms. Hayes was previously employed as an Independent Director by Apollomics, Inc., an Independent Director by TuSimple Holdings, Inc., an Independent Director by Gracell Biotechnologies, Inc., an Independent Director by Xinyuan Real Estate Co. Ltd., an Independent Director by Mogu, Inc., an Independent Director by TuanChe Ltd., a Senior Manager & Audit Partner by Deloitte & Touche Tohmatsu CPA Ltd. /Beijing/, and a Reporting Manager-SEC & U.S. GAAP by The PMI Group, Inc. She also served on the board at SharkNinja, Inc. She received her undergraduate degree from the University of International Business & Economics and an MBA from Cheung Kong Graduate School of Business.

Min-Jui Shen: Min-Jui Shen is the founder of RS Technology Ventures LLC, which was founded in 2016. He is currently working as the Managing Director at RS Technology Ventures LLC. He is also currently serving as an Independent Director at Burning Rock Biotech Ltd. since 2020. Previously, Mr. Shen worked at Illumina, Inc. from 2000 to 2016 as the Director-Scientific Operations & Research. He also held the position of Senior Vice President-Research & Development at Pacific Biosciences of California, Inc. Mr. Shen was the Chief Product Officer at Omniome LLC from 2020 to 2021. In terms of education, Mr. Shen completed his undergraduate degree at the University of California, Los Angeles in 1986 and obtained his doctorate degree from Lsu Medical School in 1992.

Licen Xu: Licen Xu is an Independent Director at Ribbon Biolabs GmbH, an Independent Director at Burning Rock Biotech Ltd., and the Chief Commercial Officer at FlashDx, Inc. Previously, Xu held positions as the VP-Strategic Marketing & Product Management at Illumina, Inc. and as the Vice President at Roche Diagnostics (Suzhou) Ltd. Xu holds a doctorate from the University of Zurich and a graduate degree from Tsinghua University.

燃石医学